Starry(603520)2025-01-16 07:46Financial Performance Expectations - The company expects a net loss attributable to shareholders of the parent company for 2024 to be between -31 million and -25 million RMB, indicating a significant decline compared to the previous year's profit of 44.23 million RMB[4]. - The projected net profit attributable to shareholders after deducting non-recurring gains and losses for 2024 is expected to be between -39 million and -33 million RMB, compared to 35.71 million RMB in the previous year[4]. - The company reported a total profit of 45.35 million RMB in the previous year, with a net profit attributable to shareholders of 44.23 million RMB[5]. Revenue and Sales Growth - The company anticipates a sales revenue growth of approximately 10% in 2024 due to the expansion of business scale and coverage area[7]. - The company has received registration approval for new formulations, which will contribute to sales in 2024[7]. - The sales expenses are expected to increase compared to the previous year due to the expansion of the company's business[7]. Cost Factors and Risks - The increase in depreciation costs due to fixed asset investments and rising raw material costs are key factors contributing to the expected losses in 2024[7]. - Investors are advised to be cautious regarding investment risks based on the preliminary nature of the forecast data[9]. Audit and Reporting - The company has communicated with its annual audit accounting firm regarding the performance forecast, indicating no major uncertainties affecting the accuracy of the forecast[8]. - The data provided in the performance forecast is preliminary and subject to change, with the final figures to be disclosed in the official annual report[9].